Meloxicam
- Product NDC
- 80425-0585
- Requested package NDC
- 80425-0585-3
- 11-digit product format
- 804250585
- Labeler code
- 80425
- Product ID
- 80425-0585_57126403-c27a-e7d2-e063-6294a90abea6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Meloxicam
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Advanced Rx of Tennessee, LLC
- Application
- ANDA077882
- Marketing category
- ANDA
- Marketing start
- 2026-06-18
- Substance
- MELOXICAM
- Active strength
- 15 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents; Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A077882-001 | MELOXICAM | MELOXICAM | 7.5MG | TABLET / ORAL | AB | 2006-07-20 | |
| A077882-002 | MELOXICAM | MELOXICAM | 15MG | TABLET / ORAL | AB | 2006-07-20 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A077882-001 | AB |
| A077882-002 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077882-001 | MELOXICAM | 7.5MG | TABLET / ORAL | AB | 2006-07-20 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A077882-002 | MELOXICAM | 15MG | TABLET / ORAL | AB | 2006-07-20 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A077882-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A077882-002 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 5488ccc1-e416-e5d7-e063-6294a90a6cb8 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 548ec3b7-2b6d-cd9e-e063-6394a90a78ff | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 80425-0585-3 80425-0585 80425058503 |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 548ef3ed-ab67-ec85-e063-6294a90ab1da | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Terrain Pharmaceuticals, Inc. | b603255e-1fcf-42ec-ab62-9aa321cb7ac6 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Bryant Ranch Prepack | 7895f389-1509-4e03-8668-526ab1627fc8 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 445d7cbf-bd3e-a54f-e063-6294a90a67a5 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 445dc4f6-daac-e2f1-e063-6394a90a0ca5 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
| Meloxicam | MELOXICAM | Advanced Rx of Tennessee, LLC | 453c5328-090e-0159-e063-6394a90a06b7 | 2025-12-05 | Boxed warning, Warnings, Adverse reactions | 077882 ANDA077882 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Meloxicam
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MELOXICAM | 15 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| VG2QF83CGL | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 152695 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 548ec3b7-2b6d-cd9e-e063-6394a90a78ff | Available on FDA.report |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Status |
|---|---|---|---|---|---|---|
| 80425-0585-3 | 80425058503 | 90 TABLET in 1 BOTTLE (80425-0585-3) | 90 tablet | 2026-06-18 | 0 | Current |